These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33049588)

  • 1. Intermediate phenotype of ATP13A2 mutation in two Chilean siblings: Towards a continuum between parkinsonism and hereditary spastic paraplegia.
    Miranda M; Harmuth F; Bustamante ML; Rossi M; Sturm M; Magnusson ÓT; Bauer P; Klockgether T; Ramirez A
    Parkinsonism Relat Disord; 2020 Dec; 81():45-47. PubMed ID: 33049588
    [No Abstract]   [Full Text] [Related]  

  • 2. Loss-of-function mutations in the ATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78).
    Estrada-Cuzcano A; Martin S; Chamova T; Synofzik M; Timmann D; Holemans T; Andreeva A; Reichbauer J; De Rycke R; Chang DI; van Veen S; Samuel J; Schöls L; Pöppel T; Mollerup Sørensen D; Asselbergh B; Klein C; Zuchner S; Jordanova A; Vangheluwe P; Tournev I; Schüle R
    Brain; 2017 Feb; 140(2):287-305. PubMed ID: 28137957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From PARK9 to SPG78: The clinical spectrum of ATP13A2 mutations.
    Erro R; Picillo M; Manara R; Pellecchia MT; Barone P
    Parkinsonism Relat Disord; 2019 Aug; 65():272-273. PubMed ID: 31151786
    [No Abstract]   [Full Text] [Related]  

  • 4. A novel ATP13A2 variant causing complicated hereditary spastic paraplegia.
    Zhang F; Liu P; Li J; Cen Z; Luo W
    Neurol Sci; 2024 Apr; 45(4):1749-1753. PubMed ID: 38252374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and ultrastructural findings in an ataxic variant of Kufor-Rakeb syndrome.
    Pietrzak A; Badura-Stronka M; Kangas-Kontio T; Felczak P; Kozubski W; Latos-Bielenska A; Wierzba-Bobrowicz T; Florczak-Wyspianska J
    Folia Neuropathol; 2019; 57(3):285-294. PubMed ID: 31588715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kufor-Rakeb Syndrome/PARK9: One Novel and One Possible Recurring Ashkenazi ATP13A2 Mutation.
    Inzelberg R; Estrada-Cuzcano A; Laitman Y; De Vriendt E; Friedman E; Jordanova A
    J Parkinsons Dis; 2018; 8(3):399-403. PubMed ID: 29966207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel homozygous mutation in ATP13A2 gene causing pure hereditary spastic paraplegia.
    Ban R; Pu C; Fang F; Shi Q
    Parkinsonism Relat Disord; 2021 May; 86():58-60. PubMed ID: 33862550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ataxia-myoclonus syndrome due to a novel homozygous ATP13A2 mutation.
    De Michele G; Galatolo D; Lieto M; Fico T; Saccà F; Santorelli FM; Filla A
    Parkinsonism Relat Disord; 2020 Jul; 76():42-43. PubMed ID: 32559632
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical and genetic analysis of ATP13A2 in hereditary spastic paraplegia expands the phenotype.
    Estiar MA; Leveille E; Spiegelman D; Dupre N; Trempe JF; Rouleau GA; Gan-Or Z
    Mol Genet Genomic Med; 2020 Mar; 8(3):e1052. PubMed ID: 31944623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel mutations in ATP13A2 associated with mixed neurological presentations and iron toxicity due to nonsense-mediated decay.
    Kırımtay K; Temizci B; Gültekin M; Yapıcı Z; Karabay A
    Brain Res; 2021 Jan; 1750():147167. PubMed ID: 33091395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered apoptosis regulation in Kufor-Rakeb syndrome patients with mutations in the ATP13A2 gene.
    Radi E; Formichi P; Di Maio G; Battisti C; Federico A
    J Cell Mol Med; 2012 Aug; 16(8):1916-23. PubMed ID: 22117566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Juvenile dystonia-parkinsonism syndrome caused by a novel p.S941Tfs1X ATP13A2 (PARK9) mutation.
    Martino D; Melzi V; Franco G; Kandasamy N; Monfrini E; Di Fonzo A
    Parkinsonism Relat Disord; 2015 Nov; 21(11):1378-80. PubMed ID: 26421390
    [No Abstract]   [Full Text] [Related]  

  • 13. Recessively inherited parkinsonism: effect of ATP13A2 mutations on the clinical and neuroimaging phenotype.
    Brüggemann N; Hagenah J; Reetz K; Schmidt A; Kasten M; Buchmann I; Eckerle S; Bähre M; Münchau A; Djarmati A; van der Vegt J; Siebner H; Binkofski F; Ramirez A; Behrens MI; Klein C
    Arch Neurol; 2010 Nov; 67(11):1357-63. PubMed ID: 21060012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinsonism and spastic paraplegia type 7: Expanding the spectrum of mitochondrial Parkinsonism.
    De la Casa-Fages B; Fernández-Eulate G; Gamez J; Barahona-Hernando R; Morís G; García-Barcina M; Infante J; Zulaica M; Fernández-Pelayo U; Muñoz-Oreja M; Urtasun M; Olaskoaga A; Zelaya V; Jericó I; Saez-Villaverde R; Catalina I; Sola E; Martínez-Sáez E; Pujol A; Ruiz M; Schlüter A; Spinazzola A; Muñoz-Blanco JL; Grandas F; Holt I; Álvarez V; López de Munaín A
    Mov Disord; 2019 Oct; 34(10):1547-1561. PubMed ID: 31433872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenic effects of novel mutations in the P-type ATPase ATP13A2 (PARK9) causing Kufor-Rakeb syndrome, a form of early-onset parkinsonism.
    Park JS; Mehta P; Cooper AA; Veivers D; Heimbach A; Stiller B; Kubisch C; Fung VS; Krainc D; Mackay-Sim A; Sue CM
    Hum Mutat; 2011 Aug; 32(8):956-64. PubMed ID: 21542062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATP13A2 mutations impair mitochondrial function in fibroblasts from patients with Kufor-Rakeb syndrome.
    Grünewald A; Arns B; Seibler P; Rakovic A; Münchau A; Ramirez A; Sue CM; Klein C
    Neurobiol Aging; 2012 Aug; 33(8):1843.e1-7. PubMed ID: 22296644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease.
    Di Fonzo A; Chien HF; Socal M; Giraudo S; Tassorelli C; Iliceto G; Fabbrini G; Marconi R; Fincati E; Abbruzzese G; Marini P; Squitieri F; Horstink MW; Montagna P; Libera AD; Stocchi F; Goldwurm S; Ferreira JJ; Meco G; Martignoni E; Lopiano L; Jardim LB; Oostra BA; Barbosa ER; ; Bonifati V
    Neurology; 2007 May; 68(19):1557-62. PubMed ID: 17485642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical spectrum of Kufor-Rakeb syndrome in the Chilean kindred with ATP13A2 mutations.
    Behrens MI; Brüggemann N; Chana P; Venegas P; Kägi M; Parrao T; Orellana P; Garrido C; Rojas CV; Hauke J; Hahnen E; González R; Seleme N; Fernández V; Schmidt A; Binkofski F; Kömpf D; Kubisch C; Hagenah J; Klein C; Ramirez A
    Mov Disord; 2010 Sep; 25(12):1929-37. PubMed ID: 20683840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reply: Complicated hereditary spastic paraplegia due to ATP13A2 mutations: what's in a name?
    Schüle R
    Brain; 2017 Dec; 140(12):e74. PubMed ID: 29112700
    [No Abstract]   [Full Text] [Related]  

  • 20. Complicated hereditary spastic paraplegia due to ATP13A2 mutations: what's in a name?
    de Bot S; Kamsteeg EJ; Van De Warrenburg BPC
    Brain; 2017 Dec; 140(12):e73. PubMed ID: 29112699
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.